Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Alaunos Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 167 | 1 | 149 | −17 |
| Shares | 142.9M | 6.00K | 100.5M | −42.5M (−29.7%) |
| Value | $155.9M | $6.00K | $65.8M | −$90.0M (−57.8%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 232,438 | $152.0K | 0.02% |
| Mirabella Financial Services LLP | 72,900 | $47.0K | 0.01% |
| Boothbay Fund Management, LLC | 55,034 | $36.0K | 0.00% |
| Exane Derivatives | 40,660 | $26.5K | 0.01% |
| Amalgamated Financial Corp. | 34,236 | $22.0K | 0.00% |
| Flow Traders U.S. LLC | 23,532 | $15.0K | 0.00% |
| Wolverine Trading, LLC | 16,518 | $11.0K | 0.00% |
| Meeder Asset Management Inc | 15,087 | $9.00K | 0.00% |
| Cerity Partners LLC | 13,600 | $9.00K | 0.00% |
| Chicago Partners Investment Group LLC | 14,025 | $7.00K | 0.00% |
| Xponance, Inc. | 10,183 | $7.00K | 0.00% |
| Magnus Financial Group LLC | 11,000 | $7.00K | 0.00% |
| Point72 Hong Kong Ltd | 8,168 | $5.00K | 0.00% |
| Federated Hermes, Inc. | 2,955 | $2.00K | 0.00% |
| FMR LLC | 806 | $1.00K | 0.00% |
| TCWP LLC | 585 | $0 | 0.00% |
| IFP Advisors, Inc | 9,520 | – | – |
Sold out (34)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
Not filed for Q1 2022 yet (1)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Carroll Financial Associates, Inc. | 6,000 | $6.00K |